Agreement with Medworxx Covers Acute Care Beds in Nova Scotia
05 Dezember 2011 - 5:47PM
PR Newswire (Canada)
TORONTO, Nov. 7, 2011 /CNW/ - Medworxx Inc. ("Medworxx") , a leader
in clinical patient flow, compliance and education solutions,
announces that the province of Nova Scotia has awarded the company
with a $1.8 million contract to license its flagship patient flow
solution for the majority of acute care beds in the province. The
project, administered under Innovation Fund, enables the province
to address issues of overcapacity that challenge hospitals daily.
Nova Scotia is the fourth province to fully-scope a patient flow
management agreement with Medworxx. "Over time we expect that each
patient will have better access to beds and a specific plan for
admission and discharge," said Tim Guest, Vice President of Acute
Care, Annapolis Valley District Health and Project Sponsor. "This
will help hospitals serve more patients seamlessly and quickly."
Nova Scotia currently deals with between 50 and 70 patients waiting
for hospital beds daily, and hospitals are over capacity on most
days. With the initiation of the Medworxx Patient Flow solution it
is anticipated that, over time, patients will have better access to
beds and more specific plans for admission and discharge. "As a
government, we are committed to delivering better care sooner to
Nova Scotians throughout the province. This new electronic solution
will help us, as a health system, better manage the flow of
patients in hospitals on a province-wide basis, leading to a more
efficient use of beds and better care sooner for Nova Scotians. It
will also help us better manage costs and, as a result, live within
our means," said Maureen MacDonald, Minister of Health and
Wellness. As the result of competitive vendor assessment process,
Medworxx was identified as the vendor of choice to support the bed
utilization project. "We very much support Nova Scotia's alignment
on making healthcare better for citizens and we're grateful to have
been selected as part of the progressive solutions the province is
undertaking. The entire team is focused on creating
equilibrium between long term quality improvements and long term
savings. We all believe we've set the stage well to succeed on both
fronts," said Niels Tofting, Senior Vice President of Sales at
Medworxx. Nova Scotia is currently operating 3000 acute care beds;
and the province has committed to a five year contract at a cost of
approximately $360K per annum for the licensing and maintenance of
the Medworxx Utilization Management System for 2,500 beds and the
Medworxx Bed Optimization System for 3,000 beds. Provincial
stakeholders regard the broad scale of the project as a foundation
for hospitals to leverage information technology to improve service
and quality. Medworxx is already working at the provincial level
with New Brunswick, Alberta and British Columbia, where Medworxx
contracts cover 10,900 beds of the 22,300 available. Medworxx
Patient Flow Solution delivers daily assessments of every patient,
and provides perspectives on a variety of patient populations to
determine appropriateness of each admission and every continued day
of care. Medworxx improves patient flow in hospitals by identifying
barriers, delays, and interruptions to plans of care for immediate
resolution, and by establishing a common framework for
interdisciplinary care coordination. About Medworxx The Medworxx
Community of Care engages almost 300 hospitals across Canada,
United States and United Kingdom to manage daily challenges in
clinical patient flow, and requirements in compliance and
education. Medworxx Utilization Management System - the flagship of
the Patient Flow Solution - currently serves over 30% of the
patient beds in Canadian hospitals. Founded in 2004, Medworxx Inc.
is based in Toronto, Ontario, Canada and serves international
markets. The company is publicly traded on the TSX Venture Exchange
. For more information, visit www.medworxx.com. The
statements made in this press release may contain forward-looking
statements that may involve a number of risks and uncertainties.
Actual events or results could differ materially from the company's
expectations and projections. The TSX Venture Exchange has not
reviewed this press release and neither approved nor disapproved
the information contained in this press release. Medworxx Inc.
CONTACT: Julia Zarb, PhDSVP Marketing & Strategy, Medworxx
Inc.Suite 700, 121 Richmond St West, Toronto, Canada M5H 2K1T:
1.800.321.1591 | T:416.642.1278 x322 | M:
416.418.3641Jzarb@medworxx.com | www.Medworxx.comDan
MatlowPresident & CEO, Medworxx Inc.Suite 700, 121 Richmond St
West, Toronto, Canada M5H 2K1T: 1.800.321.1591 | T:416.642.1278
x311| M: 416.418.3641dmatlow@medworxx.com | www.Medworxx.com
Copyright
Mineworx Technologies (TSXV:MWX)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Mineworx Technologies (TSXV:MWX)
Historical Stock Chart
Von Jun 2023 bis Jun 2024